Clinical
New Expert Guidelines from IWGDF Highlight the Growing International Recognition of Topical Oxygen Therapy (TOT) for Diabetic Foot Ulcers
The International Working Group on the Diabetic Foot (IWGDF) have recently released updated guidelines recommending the use of topical oxygen therapy (TOT) for wound healing. The updated guidelines endorse TOT as an adjunct therapy in the treatment of diabetic foot ulcers (DFUs). With its endorsement by leading experts in the field, this ground-breaking therapy is poised to transform the lives of millions of people worldwide, offering renewed hope for effective healing and improved quality of life.
This comprehensive set of recommended DFU interventions, developed by a panel of renowned experts in the field whose mission is to prevent and manage diabetic foot disease, serves as a trusted resource for healthcare professionals worldwide. With its inclusion in the IWGDF guidelines, topical oxygen therapy emerges as a vital tool, poised to revolutionize the management and healing of foot ulcers in individuals with diabetes.
Read MoreHealth Technology Wales Guidance Advises Routine Adoption of NATROX® O₂
Health Technology Wales (HTW) has published Guidance advising the routine adoption of NATROX® O₂ for the treatment of chronic, non-healing and complex diabetic foot ulcers (DFUs).
“We have the opportunity right now to reshape the future. We’ve all seen the statistics on diabetes—and frankly, they’re depressing. What motivates our team is seeing the positive impact NATROX® O₂ makes on patients every day. Being included in this Guidance is another step towards shaping a future we can all feel inspired by,” said Kennedy.
Read MoreNew Expert Opinion in Support of Topical Oxygen Therapy (TOT)
Experts agree that “topical oxygen therapy has come of age and the evidence supporting its efficacy in healing chronic diabetic foot ulcers can no longer be disputed.”
Read MoreDelphi Consensus on Guidelines for the Use of Topical Oxygen
Delphi participants reached a consensus on when to prescribe topical oxygen therapy (TOT). Experts recommend using TOT in diabetic foot ulcers (DFUs) and supported payer reimbursement for this therapy modality. Experts agreed TOT should be considered in the following circumstances: Wound types likely to benefit: DOWNLOAD NOW
Read MoreHow wound care clinicians can optimize clinical outcomes and resources
Dr. Aliza Lee, DPM, MS, ABPM, Director of Podiatric Medical Education, Staff Podiatrist, and Clinical Research Investigator (at the V.A. Hospital in Salem, Virginia presents her latest 12-week study on 8 patients exploring the combined use of NATROX® O₂ with an advanced digital platform using Telehealth to understand the clinical benefits.
Read MoreNew poster presented at DFCon 2022 by Dr. Lee
Managing patients with chronic non-healing wounds is challenging particularly for those in rural communities. This small, pilot study over 12-week study aimed to explore whether NATROX® Oxygen Wound Therapy (cTOT) in conjunction with an advanced digital platform with telehealth capabilities can offer clinical benefits while optimizing the limited clinical resources. During the study, patient-clinician interactions…
Read MoreNATROX® O₂ Masterclass Guide
A new guide has been published in Wound Masterclass. It provides an overview on NATROX® O₂ and how it works. It covers what wounds are suitable and what wounds are not. It shows the stages of treatment, and also covers the clinical evidence and efficacy, including data on wound size reduction.
Read MoreNew NATROX® IQ Video Now Available
A new introduction video has just been released to help you better understand what NATROX® IQ is and how it can help clinicians to manage their wound care caseloads. It’s just over one minute long, making it easy to watch. Check it out on the Resources section of our website here.
Read MoreNew Evidence in Support of Topical Oxygen Therapy (TOT)
A new publication by the American Diabetes Association presents the latest evidence-based therapies for diabetic foot ulcers (DFUs). Contributing authors include heavy hitters such as Andrew Boulton, David Armstrong, Magnus Löndahl, and Robert Frykberg.
They review the most recently published evidence-based data concerning topical oxygen therapies in addition to looking at future treatment approaches in the development pipeline, as well as the emerging role of wearable technologies.
Throughout the compendia, the authors present their view of current and forthcoming treatment options and identify areas worthy of additional research in the years ahead.
Read MoreNATROX® Wound Care Expands into the Digital Arena with the Launch of NATROX® IQ
NATROX® Wound Care expands into the digital arena with the launch of its new offering, NATROX® IQ. The advanced wound hub is a digital service designed specifically for wound care teams to help manage caseloads more effectively. Clinicians can achieve consistency when capturing and documenting patient wound data. Available now through distribution partners in Hong Kong and Malaysia, NATROX® IQ is designed to make wound documentation easier.
“This new offering bolsters our ongoing effort to support clinicians,” said Craig Kennedy, CEO of NATROX® Wound Care. “Our company is founded on bringing new, innovative technology to market. NATROX® IQ delivers an intelligent solution designed specifically for wound care clinicians.”
Read More